OCUL Insider Trading

Insider Ownership Percentage: 2.30%
Insider Buying (Last 12 Months): $530,954.14
Insider Selling (Last 12 Months): $2,691,191.43

Ocular Therapeutix Insider Trading History Chart

This chart shows the insider buying and selling history at Ocular Therapeutix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ocular Therapeutix Share Price & Price History

Current Price: $8.18
Price Change: Price Decrease of -0.09 (-1.09%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for OCUL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ocular Therapeutix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/23/2026Jeffrey S. HeierInsiderSell3,057$8.28$25,311.96323,368View SEC Filing Icon  
2/23/2026Peter KaiserInsiderSell2,810$8.28$23,266.80269,108View SEC Filing Icon  
2/23/2026Pravin DugelInsiderSell20,056$8.28$166,063.683,013,022View SEC Filing Icon  
2/23/2026Sanjay NayakInsiderSell1,759$8.28$14,564.52330,653View SEC Filing Icon  
2/20/2026Nadia WaheedInsiderSell3,510$7.74$27,167.40314,907View SEC Filing Icon  
2/20/2026Richard L. LindstromDirectorBuy60,229$7.66$461,354.14246,933View SEC Filing Icon  
2/12/2026Donald NotmanCOOSell11,446$9.04$103,471.84366,356View SEC Filing Icon  
2/12/2026Nadia WaheedInsiderSell7,863$9.04$71,081.52318,417View SEC Filing Icon  
2/12/2026Pravin DugelInsiderSell124,882$9.04$1,128,933.283,033,078View SEC Filing Icon  
2/12/2026Sanjay NayakInsiderSell10,348$9.04$93,545.92332,412View SEC Filing Icon  
2/4/2026Donald NotmanCOOSell6,035$8.54$51,538.90377,802View SEC Filing Icon  
2/2/2026Donald NotmanCOOSell5,455$9.14$49,858.70383,837View SEC Filing Icon  
10/8/2025Todd AndermanInsiderSell11,132$12.34$137,368.8887,568View SEC Filing Icon  
10/2/2025Jeffrey S. HeierInsiderSell10,502$11.04$115,942.08249,409View SEC Filing Icon  
10/2/2025Peter KaiserInsiderSell9,653$11.03$106,472.59194,440View SEC Filing Icon  
9/2/2025Donald NotmanInsiderSell1,066$12.43$13,250.38308,807View SEC Filing Icon  
8/25/2025Jeffrey S. HeierInsiderSell3,063$12.04$36,878.52259,911View SEC Filing Icon  
8/25/2025Peter KaiserInsiderSell3,011$12.04$36,252.44204,093View SEC Filing Icon  
8/25/2025Pravin DugelInsiderSell21,494$12.04$258,787.763,227,244View SEC Filing Icon  
8/25/2025Sanjay NayakInsiderSell1,885$12.04$22,695.40279,738View SEC Filing Icon  
5/23/2025Jeffrey S. HeierInsiderSell3,024$7.18$21,712.32262,974View SEC Filing Icon  
5/23/2025Peter KaiserInsiderSell2,974$7.17$21,323.58207,104View SEC Filing Icon  
5/23/2025Pravin DugelInsiderSell21,219$7.18$152,352.423,499,099View SEC Filing Icon  
5/23/2025Sanjay NayakInsiderSell1,862$7.17$13,350.54281,623View SEC Filing Icon  
5/8/2025Richard L. LindstromDirectorBuy10,000$6.96$69,600.00172,704View SEC Filing Icon  
2/24/2025Pravin DugelInsiderSell21,475$6.87$147,533.253,520,318View SEC Filing Icon  
2/4/2025Donald NotmanInsiderSell11,119$7.81$86,839.39193,444View SEC Filing Icon  
1/31/2025Donald NotmanInsiderSell6,301$7.84$49,399.84204,563View SEC Filing Icon  
11/25/2024Jeffrey S. HeierInsiderSell2,948$9.01$26,561.48269,059View SEC Filing Icon  
8/23/2024Sanjay NayakInsiderSell1,832$9.02$16,524.64176,194View SEC Filing Icon  
5/23/2024Sanjay NayakInsiderSell2,274$5.84$13,280.16178,026View SEC Filing Icon  
2/26/2024Summer Road LlcMajor ShareholderBuy930,851$7.52$6,999,999.528,591,401View SEC Filing Icon  
1/31/2024Antony C. MattessichCEOSell18,338$4.95$90,773.10427,943View SEC Filing Icon  
1/31/2024Donald NotmanCFOSell6,433$4.95$31,843.35139,932View SEC Filing Icon  
1/31/2024Philip C StrassburgerGeneral CounselSell6,831$4.95$33,813.45109,218View SEC Filing Icon  
1/31/2024Rabia Gurses OzdenInsiderSell7,764$4.95$38,431.8092,767View SEC Filing Icon  
8/30/2023Antony C. MattessichCEOBuy6,500$3.81$24,765.006,500View SEC Filing Icon  
7/7/2023Rabia Gurses OzdenInsiderSell832$4.93$4,101.76100,531View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

59.21% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OCUL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ocular Therapeutix Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.2,572$31K0.0%N/A0.001%Search for SEC Filing on Google Icon
3/16/2026Avoro Capital Advisors LLC10,777,777$130.84M1.3%+5.1%4.951%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd10,018$0.12M0.0%+712.5%0.005%Search for SEC Filing on Google Icon
2/26/2026Seven Fleet Capital Management LP17,100$0.21M0.2%N/A0.008%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC65,627$0.80M0.0%+470.2%0.030%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.895,687$10.87M0.0%-14.2%0.411%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd49,073$0.60M0.0%+42.5%0.023%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC812,078$9.86M0.0%N/A0.373%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP74,317$0.90M0.0%+20.7%0.034%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.94,680$1.15M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/18/2026Twinbeech Capital LP140,350$1.70M0.1%+123.3%0.064%Search for SEC Filing on Google Icon
2/18/2026Superstring Capital Management LP418,080$5.08M2.7%N/A0.192%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC157,300$1.91M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/18/2026Man Group plc46,089$0.56M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC4,229,202$51.32M0.0%+106.5%1.943%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP154,969$1.88M0.0%+468.5%0.071%Search for SEC Filing on Google Icon
2/18/2026Catalio Capital Management LP714,501$8.67M1.6%N/A0.328%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.763,559$9.27M0.0%-65.1%0.351%Search for SEC Filing on Google Icon
2/17/2026Logos Global Management LP3,500,000$42.49M2.6%+7.7%1.608%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC12,364$0.15M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC180,723$2.19M0.0%+23.9%0.083%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers722,540$8.77M0.0%+1.2%0.332%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC25,116$0.31M0.0%+57.7%0.012%Search for SEC Filing on Google Icon
2/17/2026Paradigm Biocapital Advisors LP2,935,284$35.63M0.9%-16.1%1.348%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP592,877$7.20M0.1%+215.7%0.272%Search for SEC Filing on Google Icon
2/17/2026Amundi10,589$0.13M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC173,793$2.11M0.0%+179.3%0.080%Search for SEC Filing on Google Icon
2/17/2026Farallon Capital Management LLC18,000$0.22M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD171,524$2.08M0.0%+30.4%0.079%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP345,820$4.20M0.2%+15.3%0.159%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.84,542$1.03M0.0%+230.4%0.039%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.4,625,050$56.15M0.1%+15.5%2.125%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System150,701$1.83M0.0%+50.3%0.069%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.94,426$1.15M0.0%+583.1%0.043%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board162,810$1.98M0.0%+30.0%0.075%Search for SEC Filing on Google Icon
2/17/2026Artisan Partners Limited Partnership1,063,371$12.91M0.0%-1.2%0.488%Search for SEC Filing on Google Icon
2/17/2026Avoro Capital Advisors LLC10,777,777$130.84M1.3%+5.1%4.951%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada9,652$0.12M0.0%-97.6%0.004%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.16,504$0.20M0.0%-55.8%0.008%Search for SEC Filing on Google Icon
2/17/2026Beacon Investment Advisors LLC165,556$2.01M0.8%N/A0.076%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC440,437$5.35M0.0%+25.6%0.202%Search for SEC Filing on Google Icon
2/16/2026Spruce Street Capital LP783,999$9.52M3.1%N/A0.360%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC171,606$2.08M0.0%+3.4%0.079%Search for SEC Filing on Google Icon
2/16/2026Walleye Trading LLC18,165$0.22M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/16/2026Landscape Capital Management L.L.C.15,493$0.19M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC857,649$10.41M0.0%+108.4%0.394%Search for SEC Filing on Google Icon
2/16/2026Atlas Capital Advisors Inc.5,000$61K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/16/2026Aptus Capital Advisors LLC500,752$6.08M0.0%+24.4%0.230%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP1,377,203$16.72M0.0%-14.0%0.633%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 92,648$1.13M0.0%+29.3%0.043%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co11,976$0.15M0.0%-62.5%0.006%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC9,217$0.11M0.0%+1,077.1%0.004%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group59,300$0.72M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.293,263$3.56M0.0%N/A0.135%Search for SEC Filing on Google Icon
2/13/2026Essex Investment Management Co. LLC385,825$4.68M0.7%-2.1%0.177%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC15,172$0.18M0.0%-8.4%0.007%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP268,694$3.26M0.0%-20.9%0.123%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.1,460,457$17.73M0.0%+29.9%0.671%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey49,863$0.61M0.0%+28.1%0.023%Search for SEC Filing on Google Icon
2/13/2026State Street Corp4,196,330$50.94M0.0%+21.3%1.928%Search for SEC Filing on Google Icon
2/13/2026Caitong International Asset Management Co. Ltd6,412$78K0.2%+420.0%0.003%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC307,747$3.74M0.0%+52.9%0.141%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN255,222$3.10M0.0%+95.0%0.117%Search for SEC Filing on Google Icon
2/13/2026Y Intercept Hong Kong Ltd395,335$4.80M0.1%N/A0.182%Search for SEC Filing on Google Icon
2/13/2026Rhenman & Partners Asset Management AB265,000$3.22M0.3%+31.2%0.122%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC101,633$1.23M0.0%+20.9%0.047%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp12,309$0.15M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC791,200$9.61M0.0%N/A0.363%Search for SEC Filing on Google Icon
2/12/2026Steward Partners Investment Advisory LLC2,242$27K0.0%+124.2%0.001%Search for SEC Filing on Google Icon
2/12/2026Patient Square Capital LP490,000$5.95M1.3%-31.5%0.225%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund124,672$1.51M0.0%+14.0%0.057%Search for SEC Filing on Google Icon
2/12/2026Campbell & CO Investment Adviser LLC119,285$1.45M0.1%+959.1%0.055%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank313,300$3.80M0.0%+56.1%0.144%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC462,807$5.62M0.0%+34.0%0.213%Search for SEC Filing on Google Icon
2/12/2026Xponance LLC14,634$0.18M0.0%+33.6%0.007%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG590,721$7.17M0.0%+89.3%0.271%Search for SEC Filing on Google Icon
2/11/2026Fox Run Management L.L.C.53,092$0.65M0.1%N/A0.024%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC25,406$0.31M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC15,053$0.18M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/11/2026Erste Asset Management GmbH110,000$1.35M0.0%-53.4%0.051%Search for SEC Filing on Google Icon
2/11/2026Summer Road LLC11,108,555$134.86M97.9%-11.7%5.103%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.550,269$6.68M0.0%+95.0%0.253%Search for SEC Filing on Google Icon
2/11/2026Hilton Head Capital Partners LLC3,467$42K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/11/2026RWC Asset Management LLP14,797$0.18M0.0%-8.9%0.007%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming6,403$78K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/10/2026CIBC Asset Management Inc11,469$0.14M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.1,547,523$18.79M0.0%+94.4%0.711%Search for SEC Filing on Google Icon
2/10/2026Norges Bank73,007$0.89M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC96,032$1.17M0.0%+22.5%0.044%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC4,356,547$52.90M0.0%+30.5%2.001%Search for SEC Filing on Google Icon
2/6/2026Legato Capital Management LLC123,649$1.50M0.1%+9.6%0.058%Search for SEC Filing on Google Icon
2/6/2026Prescott Group Capital Management L.L.C.313,000$3.80M0.4%N/A0.147%Search for SEC Filing on Google Icon
2/6/2026PSP Research LLC42,853$0.52M0.5%N/A0.020%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB69,300$0.84M0.0%N/A0.033%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC43,324$0.53M0.0%+43.3%0.020%Search for SEC Filing on Google Icon
2/5/2026DNB Asset Management AS44,451$0.54M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/4/2026Empire Life Investments Inc.540,115$6.56M0.4%+115.0%0.254%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio44,200$0.54M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.14,855$0.18M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D54,245$0.66M0.0%N/A0.025%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ocular Therapeutix logo
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Read More on Ocular Therapeutix

Today's Range

Now: $8.18
Low: $8.04
High: $8.42

50 Day Range

MA: $9.53
Low: $6.88
High: $11.45

52 Week Range

Now: $8.18
Low: $5.80
High: $16.44

Volume

4,157,541 shs

Average Volume

6,351,469 shs

Market Capitalization

$1.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of Ocular Therapeutix?

Ocular Therapeutix's top insider investors include:
  1. Pravin Dugel (Insider)
  2. Donald Notman (COO)
  3. Sanjay Nayak (Insider)
  4. Jeffrey S Heier (Insider)
  5. Nadia Waheed (Insider)
  6. Donald Notman (Insider)
  7. Peter Kaiser (Insider)
  8. Richard L Md Lindstrom (Director)
  9. Todd Anderman (Insider)
Learn More about top insider investors at Ocular Therapeutix.

Who are the major institutional investors of Ocular Therapeutix?

Ocular Therapeutix's top institutional investors include:
  1. Vanguard Group Inc. — 5.43%
  2. Summer Road LLC — 5.10%
  3. Avoro Capital Advisors LLC — 4.95%
  4. Avoro Capital Advisors LLC — 4.95%
  5. Adage Capital Partners GP L.L.C. — 2.12%
  6. Geode Capital Management LLC — 2.00%
Learn More about top institutional investors of Ocular Therapeutix stock.

Which major investors are selling Ocular Therapeutix stock?

In the previous quarter, OCUL stock was sold by these institutional investors:
  1. Summer Road LLC
  2. Balyasny Asset Management L.P.
  3. Paradigm Biocapital Advisors LP
  4. Royal Bank of Canada
  5. Deltec Asset Management LLC
  6. Patient Square Capital LP
  7. Marshall Wace LLP
  8. Caption Management LLC
Within the last year, company insiders that have sold Ocular Therapeutix company stock include:
  1. Pravin Dugel (Insider)
  2. Donald Notman (COO)
  3. Sanjay Nayak (Insider)
  4. Jeffrey S Heier (Insider)
  5. Nadia Waheed (Insider)
  6. Donald Notman (Insider)
  7. Peter Kaiser (Insider)
  8. Richard L Md Lindstrom (Director)
Learn More investors selling Ocular Therapeutix stock.

Which major investors are buying Ocular Therapeutix stock?

During the previous quarter, OCUL stock was acquired by institutional investors including:
  1. Vanguard Group Inc.
  2. Janus Henderson Group PLC
  3. Geode Capital Management LLC
  4. Voloridge Investment Management LLC
  5. Renaissance Technologies LLC
  6. Spruce Street Capital LP
  7. Goldman Sachs Group Inc.
  8. State Street Corp